Overview
Narasimhan Srinivasan practices practicing medicine in Chennai, India.
Their clinical expertise encompasses Pseudotumor Cerebri Syndrome and Increased Intracranial Pressure.
They are actively involved in clinical research, co-authoring 46 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Narasimhan R. Srinivasan
Is Narasimhan R. Srinivasan a top-rated expert for Pseudotumor Cerebri Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Narasimhan R. Srinivasan is classified as an Experienced expert for Pseudotumor Cerebri Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Narasimhan R. Srinivasan participate in research or clinical trials?
Yes. Narasimhan R. Srinivasan has published 46 articles and abstracts on conditions like Pseudotumor Cerebri Syndrome. You can view a list of Narasimhan R. Srinivasan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Increased Intracranial PressureSrinivasan isExperienced. Learn about Increased Intracranial Pressure.
- Pseudotumor Cerebri SyndromeSrinivasan isExperienced. Learn about Pseudotumor Cerebri Syndrome.